Literature DB >> 34517088

BMP2-induction of FN14 promotes protumorigenic signaling in gynecologic cancer cells.

Tomohiko Fukuda1, Risa Fukuda2, Daizo Koinuma3, Aristidis Moustakas2, Kohei Miyazono4, Carl-Henrik Heldin5.   

Abstract

We previously reported that bone morphogenetic protein (BMP) signaling promotes tumorigenesis in gynecologic cancer cells. BMP2 enhances proliferation of ovarian and endometrial cancer cells via c-KIT induction, and triggers epithelial-mesenchymal transition (EMT) by SNAIL and/or SLUG induction, leading to increased cell migration. However, the downstream effectors of BMP signaling in gynecological cancer cells have not been clearly elucidated. In this study, we performed RNA-sequencing of Ishikawa endometrial and SKOV3 ovarian cancer cells after BMP2 stimulation, and identified TNFRSF12A, encoding fibroblast growth factor-inducible 14 (FN14) as a common BMP2-induced gene. FN14 knockdown suppressed BMP2-induced cell proliferation and migration, confirmed by MTS and scratch assays, respectively. In addition, FN14 silencing augmented chemosensitivity of SKOV3 cells. As a downstream effector of BMP signaling, FN14 modulated both c-KIT and SNAIL expression, which are important for growth and migration of ovarian and endometrial cancer cells. These results support the notion that the tumor promoting effects of BMP signaling in gynecological cancers are partially attributed to FN14 induction.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BMP; Endometrial cancer; FN14; Ovarian cancer; SNAIL; c-KIT

Mesh:

Substances:

Year:  2021        PMID: 34517088     DOI: 10.1016/j.cellsig.2021.110146

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  1 in total

1.  BMP2 increases hyperplasia and hypertrophy of bovine subcutaneous preadipocytes via BMP/SMAD signaling.

Authors:  Liang Yang; Weiguang Hao; Hongzhuang Wang; Wanping Ren; Peishi Yan; Shengjuan Wei
Journal:  In Vitro Cell Dev Biol Anim       Date:  2022-03-11       Impact factor: 2.416

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.